improving survival rates of head and neck cancers
Published 7 years ago • 790 plays • Length 1:36Download video MP4
Download video MP3
Similar videos
-
3:08
improved survival, toxicity & qol with pembrolizumab in head and neck cancer
-
0:50
improving head and neck cancer management post-covid
-
1:51
survival differences in head and neck cancer between asia and europe
-
2:14
innovative approaches to the treatment of head and neck cancer
-
2:12
unanswered questions in head and neck cancer
-
2:08
future directions for head and neck cancer
-
1:09
the future role of immunotherapy in head and neck cancers
-
1:59
potential of immunotherapy in head and neck cancer
-
2:41
advances in head and neck cancer
-
5:59
survival rates of hpv-related head and neck cancer
-
1:22
the extreme regimen for head and neck cancer
-
1:22
targeting egfr and lgr5 in head and neck cancer
-
3:47
novel therapies for head and neck cancers: bispecific antibodies and fusion proteins
-
1:39
metronomic chemotherapy for head and neck cancer
-
4:03
keynote-040: groundbreaking results for pembrolizumab in head and neck cancer
-
3:17
the development of immunotherapies in the treatment of relapsed metastatic head and neck cancer
-
1:59
pembrolizumab in the treatment of head and neck cancer: is there more to the story?
-
3:35
is there a use for anti-pdl-1 antibodies in recurrent head and neck cancer?
-
1:52
esmo 2022 highlights in head and neck cancer